Get All Access for $5/mo

Why Women's Health Is At The Forefront Of Tech Investment According to The Economist, women's healthtech focuses on solutions which aid most of the world's 4 billion women at some point in their lives, creating a huge potential market.

By Heather Henyon

Opinions expressed by Entrepreneur contributors are their own.

You're reading Entrepreneur Middle East, an international franchise of Entrepreneur Media.

Shutterstock.com

Innovation and startup activity in women's healthtech is increasing at an astounding rate. These startups, more and more which are led by women, are addressing challenges beyond "obvious" female health issues such as menstruation and fertility, but incorporating everything from hormonal awareness to sexual empowerment.

According to The Economist, women's healthtech focuses on solutions which aid most of the world's 4 billion women at some point in their lives, creating a huge potential market. This is in contrast to heathtech aimed at men, which often focuses on conditions which affect just a fraction of the male population, such as erectile dysfunction (estimate are 10-20% of the male population). In fact, market predictions show women's healthtech is forecast to grow to US$60 billion by 2027.

In addressing this vast opportunity, $14 billion has been invested- to put this in context, this is 3% of total healthtech funding to date. While it seems that the investment community is waking up with 2021 significantly up on previous years, this remains a remarkably untapped sector for venture investment, where women are leading the way.

A deep-rooted bias

There are multiple reasons that prohibit women's healthtech in securing funding for their growth. One of them is that women's health challenges have often been associated with taboo themes, such as menstruation, menopausal symptoms or incontinence. For example, The Guardian reported that less than 3% of publically funded research was into reproductive health, although around 30% of all women will suffer from a related issue. Premenstrual syndrome, which affects 90% of women, has had only 20% of research done as compared to that on erectile dysfunction.

Another underlying factor is that female issues have often been overlooked by the medical science, where for conditions that affect all humans, men are more commonly studied. Traditionally women's bodies were seen as too complex due to hormone fluctuations, and thus often excluded from clinical trials. One of the key underlying issues is the existing bias persisting amongst largely male investors who often prefer to fund all-male teams- a trend which Dana Kanze, Professor at London Business School, cited as "homophily," or the tendency for investors to fund those from similar backgrounds. In the words of European Women in Venture Capital (VC) founder Kinga Stanislawska, investors prefer investing "in founders that are most like them."

Related: HB Investments' Seed Investment Fund And Incubator, HB Angels, Announces Launch Of Its First Startup, Ketish, A Luxury Feminine And Sexual Wellness Brand

A call for female investors

One part of the solution is a step change in the number of female investors. Women are more likely to invest in businesses that are supplied by, led by, or catered to women, as they are more empathetic to issues unique to women, and will have an innate understanding of what they want as consumers.

A Kauffman Foundation study of female entrepreneur funding found that VC firms with female partners were two times as likely to invest in startups founded by women, and over three times more likely to invest in startups with female CEOs.

To bridge the gender investment gap, the European Commisssion's Gender Smart Financing document additionally recommends actively seeking female-led companies as targets for investment and supporting pitching by female entrepreneurs, creating new funds with a gender focus, and encouraging serial female entrepreneurs to become investors/business angels themselves.

Actively seeking such investment is the basis of "gender lens investing," which invests for financial return, while also considering the benefits to women. Gender lens investing is spearheaded by VC funds such as my company, Mindshift Capital, which has recently invested in Rosy, a women's sexual wellness platform founded by obgyn Dr. Lyndsey Harper.

Founded in 2018, Rosy is focused on providing women with access to a range of services and benefits to boost and manage their wellbeing, including sexual health guidance, and a host of expertly created educational resources including videos and self-help materials. As part of its $2 million seed round, Rosy was able to make key hires for the business, and focus on product development and marketing expansion. The funding will help the team at Rosy to continue with its growth and expansion of the membership base, and seize the huge opportunity in the sexual wellness market.

Women's healthtech is a hot space for venture capital investments. As women make up nearly 50% of the population, there is never going to be a shortage of consumers. With so many women unhappy with the current care on offer, there are endless opportunities for investors to not only support high-growth businesses and generate premium returns. They also have an opportunity to drive change and diversity in the global venture system, and invest in extraordinary female leaders who will inspire the next generation of founders.

Related: Poised For Growth: The Potential For High Return On Investment In The Emerging Femtech Sector

Heather Henyon

Founding Partner, Mindshift Capital

Heather Henyon is Founding Partner of Mindshift Capital, a global venture fund that invests exclusively in early stage women-led technology companies. Mindshift Capital has backed 18 companies led by 24 female founders in five countries.

Heather is also the founder of the Women’s Angel Investor Network (WAIN), the first and largest women’s angel investor group in the Middle East. An active venture investor with a passion for women’s health and sports, Heather has over 200 direct and fund investments in the US, Europe and Middle East. She started her career on Wall Street and has almost 20 years of experience in finance, technology and strategy in emerging markets including as founding CEO of Grameen-Jameel Microfinance Ltd.

Heather is a member of the Investment Committee of the Next Wave Impact Fund and is a founding member and former Board and Investment Committee member of Dubai Angel Investors and Cairo Angels Syndicate Fund. She serves on the Board of Directors and Audit and Risk Committee of the Sekem Holding Group in Egypt and is a Board Member of Little Thinking Minds (Jordan), Wellbees (Turkey) and QiDZ (UAE). Heather received the 2023 Cornell University Emerging Market Institute’s Cañizares Alumni Award and has been nominated as Investor of the Year by Arabian Business in 2017 and 2016. Originally from the US, she has lived in the Middle East for 15 years and speaks English, Arabic, and French.

Heather holds an MBA in finance and entrepreneurship from the Johnson School at Cornell University where she was a Park Leadership Fellow, and a BA in economics and political Science from Oberlin College.

Business News

How to Be a Billionaire By 25, According to a College Dropout Turned CEO Worth $1.6 Billion

Austin Russell became the world's youngest self-made billionaire in 2020 at age 25.

Marketing

SEO Trends You Need to Be Aware of Right Now, According to a Seasoned Pro

Navigate the future of search engine optimization to elevate your online presence and drive meaningful engagement.

Fundraising

You Don't Need Venture Capital Anymore — Here Are 4 Funding Alternatives

Are you hoping to raise capital for your business without traditional investor interference? Here are four alternatives you could pursue.

Business Ideas

63 Small Business Ideas to Start in 2024

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2024.